---
figid: PMC9495514__antioxidants-11-01705-g008
pmcid: PMC9495514
image_filename: antioxidants-11-01705-g008.jpg
figure_link: /pmc/articles/PMC9495514/figure/antioxidants-11-01705-f008/
number: Figure 8
figure_title: ''
caption: 'ICS II mitigated oxidative stress in PA-induced HepG2 cells. (a) Mito-SOX
  staining of HepG2 cells (×100, scale bar = 200 μm). (b) Relative fluorescence intensity
  (n = 5). (c) ROS level (n = 6). (d) MDA level (n = 6). (e) GSH-Px activity (n =
  6). (f) SOD activity (n = 6). (g) SOD1 activity (n = 6). (h) SOD2 activity (n =
  6). (i) SOD3 activity (n = 6). Data were expressed as mean ± SEM. ** p < 0.01 versus
  control group; #p < 0.05 and ##p < 0.01 versus PA 300 group.'
article_title: 'Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ:
  Involvement of ROS/NF-κB/IRS1 Signaling Pathway.'
citation: Yiqi Li, et al. Antioxidants (Basel). 2022 Sep;11(9):1705.
year: '2022'

doi: 10.3390/antiox11091705
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI

keywords:
- Icariside II
- Type 2 diabetes mellitus
- peroxisome proliferator-activated receptors α and γ
- oxidative stress
- inflammation

---
